IDiyas

For the Inventor, By the Inventor

Ibaraki, Japan

Akira Matsuhisa

USPTO Granted Patents = 11

Average Co-Inventor Count = 6.9

ph-index = 5

Forward Citations = 101(Granted Patents)


Location History:

  • Ushiku, JP (2002)
  • Ibaraki, JP (1990 - 2004)
  • Tsukuba-shi, Ibaraki, JP (2004)

Company Filing History:

goldMedal10 out of 329 
 
Yamanouchi Pharmaceutical Company Ltd.
 patents
silverMedal1 out of 832,680 
Other
 patents

Years Active: 1990-2004

Loading Chart...
11 patents (USPTO):
1. 6734203 - Fused imidazolium derivatives (2004-05-11),
2. 6673799 - Cyanophenyl derivative (2004-01-06),
3. 6340678 - 4,4-difluoro-2,3,4,5-tetrahydro-1H-1-benzoazepine derivatives and drug compositions containing them (2002-01-22),
4. 5856564 - Condensed benzazepine derivative and pharmaceutical composition thereof (1999-01-05),
5. 5723606 - Condensed benzazepine derivative and pharmaceutical composition thereof (1998-03-03),
6. 5710150 - Benzazepine derivative, pharmaceutical composition thereof, and (1998-01-20),
7. 5496942 - 5-substituted tetrahydrobenzimidazole compounds (1996-03-05),
8. 5420126 - 3,4-dihydro-2H-1,4-benzoxazine derivatives and pharmaceutical (1995-05-30),
9. 5344927 - Tetrahydrobenzimidazole derivatives and pharmaceutical compositions (1994-09-06),
10. 5278158 - Oxazinobenzazole compounds (1994-01-11),
11. 4977175 - 4,5,6,7-tetrahydrobenzimidazole derivatives as 5HT.sub.3 -antagonists (1990-12-11),

Title: Akira Matsuhisa: Innovator in Pharmaceutical Chemistry

Introduction

Akira Matsuhisa is a prominent inventor based in Ibaraki, Japan, known for his significant contributions to pharmaceutical chemistry. With a total of 11 patents to his name, he has made remarkable advancements in the field, particularly in the development of novel compounds with therapeutic applications.

Latest Patents

One of Matsuhisa's latest patents involves fused imidazolium derivatives, specifically a piperazino-substituted novel cyanophenyl derivative. This innovative compound features a substituted carbamoyl or substituted sulfamoyl group that may include an aryl or heterocyclic group. The compound exhibits anti-androgen action, making it useful in preventing or treating prostatic cancer, benign prostatic hyperplasia, and related diseases.

Career Highlights

Throughout his career, Matsuhisa has worked with Yamanouchi Pharmaceutical Company Ltd., where he has played a crucial role in advancing pharmaceutical research and development. His expertise in creating effective therapeutic agents has positioned him as a key figure in the industry.

Collaborations

Matsuhisa has collaborated with notable colleagues, including Isao Yanagisawa and Nobuaki Taniguchi. These partnerships have further enhanced his research capabilities and contributed to the success of his innovative projects.

Conclusion

Akira Matsuhisa's work in pharmaceutical chemistry exemplifies the impact of innovation in healthcare. His patents and collaborations reflect a commitment to developing effective treatments for serious medical conditions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…